LSP leads $28m round for Lumeon

New investor MTIP also took part in the round, alongside existing backers Gilde Healthcare, Amadeus Capital Partners and IPF Partners.

The company will invest in marketing activity and grow its US operations, including the expansion of its Boston-based team.

LSP drew capital from €280m vehicle LSP Health Economics Fund 2 to support the transaction.

Previous funding
Amadeus and Archimedia Investments led a £1.6m round for Lumeon (then known as Qinec) in November 2012. Gilde then led a £6m series-B round for the company three years later, with Amadeus and Archimedia also taking part.

The company rebranded as Lumeon in 2016; the following year, IPF injected €7m into the firm.

Company
Headquartered in London and founded in 2005, Lumeon develops software that enables healthcare providers to create and automate treatment pathways. It incorporates data analytics tools to help organisations measure and refine their services.

People
Life Sciences Partners – Rudy Dekeyser (managing partner).
Lumeon – Robbie Hughes (CEO).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Expansion
• UK / Ireland
• Technology
• United Kingdom
• Life Science Partners
• Gilde Investment Management
• Amadeus Capital
• Venture